Table 1.
Demographic, anthropometric, HIV status and other characteristics of the 223 participants
| Characteristics | 1 stLine drugs | 2 ndLine drugs | Naïve-ART | Controls |
|---|---|---|---|---|
| (n = 62) | (n = 50) | (n = 61) | (n = 50) | |
| n (%) | n (%) | n (%) | n (%) | |
| HIV status | Positive | Positive | Positive | Negative |
| Gender | ||||
| Female | 48 (77.4) | 31 (62) | 44 (72.1) | 30 (60) |
| Male | 14 (22.6) | 19 (38) | 17 (27.9) | 20 (40) |
| Mean Age ± SD | 41.1 ± 11.2 | 38.7 ± 11.3 | 36.3 ± 11.8 | 47.3 ± 13.7 |
| Mean CD4 count ± SD (cells/μL) | 382 ± 173.2 | 215.1 ± 119 | 399 ± 212.7 | / |
| Mean BMI (kg/m2) ± SD | 24.6 ± 4.2 | 23 ± 3.5 | 23.6 ± 3.8 | 28.6 ± 6 |
| Smokers | 2 (3.2) | 0 (0) | 3 (4.9) | 1 (2) |
| Alcohol consumers | 4 (6.5) | 0 (0) | 10 (16.4) | 4 (8) |
| Aerobic exercise | 20 (32.3) | 7 (14) | 18 (29.5) | 12 (24) |
| Fat mass (Kg): mean (SD) | 18.7 (9.7) | 15.3 (9.2) | 17.9 (9.5) | 26.7 (17.9) |
| Lean Body Mass (Kg): mean (SD) | 47.1 (8.9) | 46.4 (9.6) | 45.7 (11.3) | 49.3 (9.9) |
| Total body water (Kg): mean (SD) | 34.3 (6.7) | 33.9 (7.0) | 34.1 (8.5) | 36.0 (7.2) |
| Clinical staging | ||||
| Primary | 51 (82.3) | 2 (4) | 54 (88.5) | / |
| Stage 1 | 11 (17.7) | 36 (72) | 5 (8.2) | / |
| Stage 2 | 0 (0) | 12 (24) | 2 (3.3) | / |
| WHO BMI classification | ||||
| Underweight | 5 (8.1) | 7 (14) | 10 (16.4) | 3 (6) |
| Normal | 33 (53.2) | 29 (58) | 31 (50.8) | 14 (28) |
| Overweight | 18 (29) | 10 (20) | 17 (27.9) | 13 (26) |
| Obese class 1 | 5 (8.1) | 2 (4) | 3 (4.9) | 13 (26) |
| Obese class 2 | 1 (1.6) | 0 (0) | 0 (0) | 4 (8) |
| Obese class 3 | 0 (0) | 0 (0) | 0 (0) | 3 (6) |